Please login to the form below

Not currently logged in


This page shows the latest ADHD news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m

Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m

The company’s lead digital treatment in development is AKL-T01 for paediatric attention deficit/hyperactivity disorder (ADHD), which is now being reviewed by the FDA. ... If approved by the FDA, AKL-T01 would be the first prescription video game to

Latest news

More from news
Approximately 15 fully matching, plus 124 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    contingent payments for the ADHD company Neurovance; Shanghai Fosun paid $90m for a majority interest in Breas (see above); Ascendis Health paid R375m ($29m) for the Southern Africa operations of Cipla ... 320. Neurovance. Otsuka. Acquisition. Portfolio,

  • A rare talent A rare talent

    It allowed us to solidify our position as the world's largest rare disease company and we now are the leaders in haematology, lysosomal storage disorders with strong capabilities in ADHD

  • Challenging perceptions Challenging perceptions

    We try to be recognised as patient-centric by supporting and helping the overall ADHD community. ... Harnessing technology. Shire's communications efforts in ADHD have for some time included digital technology.

  • Pharma deals in February 2015 Pharma deals in February 2015

    in-house clinical and preclinical pipeline targeting serious diseases with blockbuster potential eg Alzheimer's disease, ADHD, metabolic disease, schizophrenia, migraine. ... Its initial development was focused on ADHD and other neurological diseases.

  • Experience me: building engagement through experience Experience me: building engagement through experience

    Janssen's award-winning campaigns in ADHD are a great example of this approach in operation.

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Shire elects new chair Shire elects new chair

    During that time Shire has grown substantially, although has struggled in recent years with generic competition for big-selling attention deficit-hyperactivity disorder (ADHD) drug Adderall XR and plans to downsize

  • Bray Leino opens health and wellbeing PR practice Bray Leino opens health and wellbeing PR practice

    She has worked on campaigns for ADHD brands and public affairs for Shire Pharmaceuticals: cardiology products for AstraZeneca, Sanofi and Eli Lilly; mental health for Wyeth; diagnostics and devices for Roche

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Neurodiversity, ADHD and work: Obstacles and opportunities

    2006). Characterizing cognition in ADHD: beyond executive dysfunction. Trends in cognitive sciences,  10(3), 117-123. ... 12. Hupfeld, K. E., Abagis, T. R., &Shah, P. (2018). Living “in the zone”: hyperfocus in adult ADHD. ADHD Attention Deficit

  • Havas Lynx Scoops Healthcare Agency of the Year at Cannes Lions 2018

    The second silver was in the Art Direction category for its inspired and inventive Attention Deficit Hyperactivity Disorder (ADHD) Rollercoaster campaign.

  • Attigo (part of the Mednet Group)

    For ADHD awareness month this year our Associate Medical Writer, Alex Teahan, has written a piece surrounding ADHD and employment. ... He discusses the advantages and disadvantages of ADHD at work, and areas of improvement for employers in supporting

  • ADHD perspectives series

    The ADHD in practice editorial board looks to represent this multi-disciplinary team providing insight and opinion. ... ADHD community can work together to provide the personalised 'scaffolding' from their perspective.

  • Powering behaviour change with human insights

    Lets consider for instance ADHD diagnosis in the UK, research has found that diagnosis of ADHD in school-age children grew from less than one percent in the 1990s to about

More from PMHub
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...